登录 | 注册    关注公众号  
微信公众号
搜索
 >  Protein>Siglec-3 >CD3-HP2E3

PE-Labeled Human Siglec-3 / CD33 Protein, His Tag (Site-specific conjugation)

分子别名(Synonym)

CD33,SIGLEC3,gp67

表达区间及表达系统(Source)

PE-Labeled Human Siglec-3, His Tag (CD3-HP2E3) is produced via site-specific conjugation of PE to Human Siglec-3, His Tag under optimal conditions with a proprietary technology. Human Siglec-3, His Tag is expressed from human 293 cells (HEK293). It contains AA Asp 18 - His 259 (Accession # AAH28152.1).

Predicted N-terminus: Asp 18

Request for sequence

蛋白结构(Molecular Characterization)

Online(Asp 18 - His 259) AAH28152.1

This protein carries a polyhistidine tag at the C-terminus.

The protein has a calculated MW of 29.4 kDa.

应用说明(Application)

Evaluation of anti-CD33 CAR expression by flow cytometry. Please note that this product is NOT compatible to streptavidin detection system.

Conjugate

PE

Excitation Wavelength: 488 nm / 561 nm

Emission Wavelength: 575 nm

制剂(Formulation)

Lyophilized from 0.22 μm filtered solution in PBS, 0.5% BSA, pH7.4. Normally trehalose is added as protectant before lyophilization.

Contact us for customized product form or formulation.

重构方法(Reconstitution)

Please see Certificate of Analysis for specific instructions.

For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

存储(Storage)

For long term storage, the product should be stored at lyophilized state at -20°C or lower.

Please protect from light and avoid repeated freeze-thaw cycles.

This product is stable after storage at:

  1. -20°C to -70°C for 12 months in lyophilized state;
  2. -70°C for 3 months under sterile conditions after reconstitution.

活性(Bioactivity)-FACS

Biotinylated Human FACS

5e5 of anti-Siglec-3 CAR-293 cells were stained with 100 μL of 1:50 dilution (2 μL stock solution in 100 μL FACS buffer) of PE-Labeled Human Siglec-3, His Tag (Cat. No. CD3-HP2E3) and negative control protein respectively. PE signal was used to evaluate the binding activity (QC tested).

Protocol

 

背景(Background)

Myeloid cell surface antigen CD33 is also known as SIGLEC3, Siglecs (sialic acid binding Ig­like lectins) and GP67, is a single-pass type I membrane protein which belongs to the immunoglobulin superfamily and SIGLEC (sialic acid binding Ig-like lectin) family. Human CD33 / Siglec-3 cDNA encodes a 364 amino acid (aa) polypeptide with a hydrophobic signal peptide, an N-­terminal Ig-­like V­-type domain, one Ig­-like C2-­type domains, a transmembrane region and a cytoplasmic tail. CD33 / Siglec-3 usually considered myeloid-specific, but it can also be found on some lymphoid cells. In the immune response, CD33 / Siglec-3 may act as an inhibitory receptor upon ligand induced tyrosine phosphorylation by recruiting cytoplasmic phosphatase(s) via their SH2 domain(s) that block signal transduction through dephosphorylation of signaling molecules. CD33 / Siglec-3 induces apoptosis in acute myeloid leukemia.

 

 

前沿进展

 
 
货号/价格
文档
联系电话:
+86 400-682-2521(全国)
010-53681107(北京)
021-50850665(上海)
运输方式
订单邮箱:
order.cn@acrobiosystems.com
技术支持邮箱:
tech.cn@acrobiosystems.com
Siglec-3靶点信息
英文全称:Myeloid cell surface antigen CD33
中文全称:髓系细胞表面抗原CD33
种类:Homo sapiens
上市药物数量:1详情
临床药物数量:34详情
最高研发阶段:批准上市
查看更多信息
前沿进展
点击查看详细

消息提示

请输入您的联系方式,再点击提交!

确定